Marker for diagnosing lung adenocarcinoma and application

• Main Authors: WANG DONGSHENG, ZHANG KAIJIONG, LUO HUAICHAO, WEN XIAOXIA, ZHANG XINGMEI, LIU SHAN, REN HANXIAO, ZU RUILING
• Format: Patent
• Language: Chinese; English
• Published: 04.04.2023
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS OR TEST PAPERS THEREFOR; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES; ENZYMOLOGY; HUMAN NECESSITIES; HYGIENE; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MUTATION OR GENETIC ENGINEERING; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PROCESSES OF PREPARING SUCH COMPOSITIONS; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPIRITS; VINEGAR; WINE

The invention discloses a marker for diagnosing lung adenocarcinoma and application, and relates to the technical field of biological medicines.The experimental analysis shows that blood platelets has-mi R-199b-3p have high sensitivity, specificity and accuracy for diagnosis of benign and malignant pulmonary nodules, in the actual diagnosis process, blood of a patient is collected, and then the blood of the patient is analyzed to obtain the marker for diagnosing the lung adenocarcinoma. And analyzing the content of has-mi R-199b-3p in the blood platelets through corresponding detection equipment so as to judge whether the patient suffers from lung adenocarcinoma or not. 本发明公开了一种用于诊断肺腺癌的标志物及应用，涉及生物医药技术领域，通过实验分析可知，血小板has-mi R-199b-3p对良恶性肺结节诊断具有较高的敏感性、特异性和准确性，在实际的诊断过程中，通过采集患者的血液，然后通过相应的检测设备分析血小板中has-mi R-199b-3p的含量，从而判断病人是否得了肺腺癌。